Navigation Links
China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates
Date:11/11/2009

ber 30, 2009 was $6.5 million, which is about 7% higher compared to the $6.1 million for the third quarter of 2008. Gross profit margin for the current quarter is 42%, compared to 49% in the third quarter of 2008. The lower gross profit margin in the third quarter of 2009 was due to faster revenue growth of lower margin products.

Selling and G&A expenses in the third quarter of 2009 rose to $1.3 million from $0.9 million as the company expanded its distribution network.

Given our good record on not losing any receivables, we now feel more comfortable in our ability to collect our account receivables. After analyzing our receivable collection history and also a number of other factors including macro economy and industry bad debt experience rates, management revised bad debt allowance estimates. The change in the estimate for bad debt reserve resulted in a benefit of $2.8 million for the third quarter of 2009.

Operating income for the third quarter of 2009, including the effect of the change in bad debt estimate, was $8.1 million, an increase of 72% from $4.7 million for the same period in 2008.

Net income for the third quarter of 2009 (which also includes the effect of the change in bad debt estimate) increased 69% to $7.2 million, up from $4.3 million reported in the same period of 2008. Diluted earnings per share was $0.17 in the third quarter of 2009, compared to $0.10 in the third quarter of 2008.

Balance Sheet

As of September 30, 2009, the Company had cash and cash equivalents of $3.8 million, which represented 4.0% of total assets, compared to $6.9 million, or 9.2% of total assets, as of December 31, 2008.

    Business Update
    -- On August 18, 2009, the Company announced that it has received official
       approval from China's State Food and Drug Administration ("SFDA") for
       the production of generic Omeprazole Sodium for Injection. Omepra
'/>"/>
SOURCE China Pharma Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2009 Results
2. China Medicine Announces Conference Call to Discuss Third Quarter 2009 Results
3. Monsanto Opens First Biotechnology Research Center in China
4. Chinas Research Output More Than Doubled Since 2004, Thomson Reuters Study Reveals
5. China-Biotics, Inc. Appoints New Vice President
6. Blue Dye Test Alternative Installed at Bayer China for Packaging Quality Assurance Process
7. China Biologic Named to Forbes Magazines Fifth Annual List of Asias 200 Best Under a Billion
8. China Medical Technologies to Exhibit its Products at China International Medical Equipment Fair in Chengdu, China
9. China Medical Technologies Announces the SFDA Approval for its SPR System
10. China Integrated Energy, Inc. Announces Preliminary Third Quarter Financial Results and Increases Full Year Guidance
11. China Integrated Energy, Inc. Announces Eight Million Share Public Follow-On Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 China Biologic ... "Company"), a leading fully integrated plasma-based biopharmaceutical company ... that its majority-owned subsidiary, Shandong Taibang Biological Products ... certification from the China Food and Drug Administration ... facility. As previously disclosed in the Company,s public ...
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich ... that the waiting period under the Hart-Scott-Rodino Antitrust ... acquisition expired on December 22, 2014, thereby completing ... requirement for the acquisition of the Company by ... antitrust clearance satisfies another condition to closing the ...
(Date:12/22/2014)... 2014 The Center for Professional ... technical training across the life sciences industry, has partnered ... (SCDM) to provide the organization's members with discounted classroom ... to the more than 350 sessions across 80 course ... off when registering for a public course ...
(Date:12/22/2014)... CHAPEL HILL, N.C. , Dec. 22, 2014 ... ALNE) today announced that it has signed a ... biotechnology company that has developed and patented a ... and medical diagnostics products that enable rapid on-site ... and alcohol use/abuse and health issues in an ...
Breaking Biology Technology:China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3ALNE Announces Intention To Acquire BioTechPharma 2
... FRANCISCO, Oct. 2 Epiphany Biosciences,Inc. announced today ... of,Lead Director. Dr. Sanders is a highly experienced ... of Genentech.,He has also served as chief executive ... the board from 1992-1995. In addition, Dr. Sanders ...
... VIEJO, Calif., Oct. 2 Clarient, Inc.,(Nasdaq: ... testing services,resource for pathologists, oncologists and the pharmaceutical ... is featured in an,exclusive interview on WallSt.net,s 3-Minute ... overview of the company, and the,significance of the ...
... LA JOLLA, Calif., Oct. 1 TorreyPines Therapeutics, Inc.,(Nasdaq: ... successful End-of-Phase II,meeting for tezampanel with the U.S. Food ... a review of the Phase II data, the FDA ... tezampanel in acute,migraine. The FDA also confirmed that the ...
Cached Biology Technology:[video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.net's 3-Minute Press Show 2TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel 2TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel 3TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel 4
(Date:12/17/2014)... 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend upcoming ... medical sensors in biomedical applications. Chemical sensors help ... correct diagnosis during surgical procedures. The Global Chemical ...
(Date:12/15/2014)... 2014 Research and Markets ( ... "Global Facial Recognition Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is a ... recognition system measures the overall facial feature of ... and the distance between eyes. Facial recognition is ...
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the ... 2015-2019" report to their offering. ... is the adoption of multimodal biometric systems. Multimodal ... an individual for verification and identification purposes. This ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... KINGSTON, R.I. March 1, 2010 In one of ... of natural and social scientists from the University of Rhode ... among the most important factors driving the success of marine ... marine reserve is just about coral, fish and other aquatic ...
... researchers have found a way to stitch graphene and ... offers new paths of exploration for materials scientists. ... in microelectronics that scale well below the limitations of ... the lab of Pulickel Ajayan, Rice,s Benjamin M. and ...
... Moines, Iowa March 1, 2010 You may have ... bonobos living at Great Ape Trust, than you thought. And ... scientists more about the effect of culture on neurological disorders ... universal language, an alternative to spoken words to convey a ...
Cached Biology News:Scientists find community involvement, not only enforcement, drives success of marine reserves 2Rice researchers make graphene hybrid 2Rice researchers make graphene hybrid 3If bonobo Kanzi can point as humans do, what other similarities can rearing reveal? 2If bonobo Kanzi can point as humans do, what other similarities can rearing reveal? 3
... C-1-tetrahydrofolate synthase, cytoplasmic ... Methylenetetrahydrofolate dehydrogenase (EC ... (EC 3.5.4.9); Formyltetrahydrofolate ... [Source:Uniprot/SWISSPROT;Acc:P11586] ...
Request Info...
Lipid-rich bovine serum albumin for cell culture (1). It is chromatographically purified and has an IgG content 0.1% (w/w)....
Chicken anti-EEA1...
Biology Products: